April 2007

FDA Gets Second Chance to Argue

By Janice G. Inman

The U.S. Court of Appeals for the District of Columbia in March began reconsideration of its decision that held it was unconstitutional for the Food and Drug Administration (FDA) to withhold experimental drugs from terminally ill patients. The order for rehearing en banc was issued in November 2006. The case pits dying, often desperate, patients against the FDA and its policies aimed at protecting the public from dangerous and unproven medications.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

Pay per view ($15.00)